Are you suffering from chronic stress? Many of us are—whether we’re stressed out by our jobs, complicated relationships, caregiving responsibilities, or the general state of the world. That’s where Elissa Epel’s new book, The Stress Prescription, comes in. A health psychologist and director of the Aging, Metabolism, and Emotions Center at the University of California,…
Read MoreCMS Sticks to Sharply Limited Coverage of New Alzheimer’s Drug, Leqembi (Managed Healthcare Executive): For now, CMS (Note: Centers for Medicare & Medicaid Services) is sticking to the coverage decision it made for Aduhelm (aducanumab) and applying it Leqembi (lecanemab). The decision limits Medicare coverage of the two Alzheimer disease’s drugs to Medicare beneficiaries who…
Read MoreA lo largo de la vida, su cerebro va a experimentar un desarrollo extraordinario. Su cerebro es el órgano más adaptable y modificable de su cuerpo, y puede cambiar tanto positiva como negativamente, dependiendo de cómo lo utilice cada día. Simplemente leyendo este libro, su cerebro ha cambiado. ¿Cuánto y cómo va cambiar en los…
Read MoreAs you go through life, your brain undergoes extraordinary development. Your brain is the most adaptable, modifiable organ in your body, and it can change both positively and negatively by how you use it each day. Just by reading a book such as this one, your brain has been changed. How has your brain been…
Read MoreThe brain changes each and every day during our whole lives, based on how we use it. Healthier daily habits can improve the trajectory of our lives. “A brain that can think critically, that can function under stress, a brain that is resilient in the face of trauma, a brain that is creative, that is thoughtful,…
Read MoreAlto Neuroscience bags $25M for four Phase II drugs (Endpoints News): Another $25 million is flowing the way of a California biotech attempting to fix the “trial and error” system in neuroscience drug R&D. Alto Neuroscience picked up the capital from Alpha Wave Ventures via an extension to its Series B, bringing total equity raised…
Read MoreManifesto: Opposition to EU Reclassification of TMS and tDCS equipment to Class III devices based on flawed evidence (European Society for Brain Stimulation): It has recently come to our attention that the EU has reclassified the NIBS equipments including rTMS and tDCS, as Class III devices, the category of highest risk, similar to invasive treatments,…
Read MoreVoice analysis platform Sonde Health raises $19.25M (MobiHealthNews): AI-enabled voice technology platform Sonde Health announced it raised $19.25 million in a Series B funding round led by Partners Investment, bringing its total raise to $35.25 million … Sonde Health uses patented voice technology to detect various health conditions from biomarkers in a person’s voice, including…
Read More